| NCT04094610 |
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations |
https://ClinicalTrials.gov/show/NCT04094610 |
Recruiting |
Turning Point Therapeutics, Inc. |
2022-12-31 |
| NCT03698994 |
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03698994 |
Recruiting |
National Cancer Institute (NCI) |
2025-12-31 |
| NCT03323034 |
Pevonedistat, Irinotecan Hydrochloride, and Temozolomide in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphoma |
https://ClinicalTrials.gov/show/NCT03323034 |
Recruiting |
Children’s Oncology Group |
2021-12-01 |
| NCT03270059 |
Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System |
https://ClinicalTrials.gov/show/NCT03270059 |
Recruiting |
OHSU Knight Cancer Institute |
2022-08-15 |
| NCT03245151 |
Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors |
https://ClinicalTrials.gov/show/NCT03245151 |
Recruiting |
Eisai Inc. |
2022-05-31 |
| NCT03206021 |
Treatment of Children With Recurrent Refractory Brain/Solid Tumors and Recurrent Ependymoma |
https://ClinicalTrials.gov/show/NCT03206021 |
Recruiting |
The Hospital for Sick Children |
2021-07-01 |
| NCT03188354 |
Diagnostic Assessment of 18F-fluciclovine and 18F-FDG -PET/MRI of Primary Central Nervous System Lymphoma |
https://ClinicalTrials.gov/show/NCT03188354 |
Recruiting |
Norwegian University of Science and Technology |
2021-12-31 |
| NCT03150862 |
A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Subjects With Newly Diagnosed or Recurrent Glioblastoma |
https://ClinicalTrials.gov/show/NCT03150862 |
Active, not recruiting |
BeiGene |
2021-06-30 |
| NCT03012620 |
Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types |
https://ClinicalTrials.gov/show/NCT03012620 |
Recruiting |
UNICANCER |
2023-01-31 |
| NCT02975882 |
Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT02975882 |
Recruiting |
Children’s Oncology Group |
2020-06-03 |
| NCT03233204 |
Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03233204 |
Recruiting |
National Cancer Institute (NCI) |
2024-09-30 |
| NCT02932280 |
Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment |
https://ClinicalTrials.gov/show/NCT02932280 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-10-31 |
| NCT03220035 |
Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03220035 |
Recruiting |
National Cancer Institute (NCI) |
2023-12-31 |
| NCT02808650 |
Prexasertib in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT02808650 |
Active, not recruiting |
Children’s Oncology Group |
2019-12-31 |
| NCT02797366 |
Proton Radiotherapy for Primary Central Nervous System Tumours in Adults |
https://ClinicalTrials.gov/show/NCT02797366 |
Recruiting |
Uppsala University |
2020-07-31 |
| NCT02793466 |
Durvalumab in Pediatric and Adolescent Patients |
https://ClinicalTrials.gov/show/NCT02793466 |
Recruiting |
Children’s Hospital Los Angeles |
2019-12-31 |
| NCT02780804 |
Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT02780804 |
Active, not recruiting |
National Cancer Institute (NCI) |
2022-04-30 |
| NCT03213704 |
Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03213704 |
Recruiting |
National Cancer Institute (NCI) |
2024-09-30 |
| NCT02710240 |
Indocyanine Green for Central Nervous System Tumors |
https://ClinicalTrials.gov/show/NCT02710240 |
Active, not recruiting |
Abramson Cancer Center of the University of Pennsylvania |
2020-09-30 |
| NCT03213678 |
PI3K/mTOR Inhibitor LY3023414 in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03213678 |
Recruiting |
National Cancer Institute (NCI) |
2024-09-30 |
| NCT02687386 |
A Study of Intravenous EEDVsMit in Children With Recurrent / Refractory Solid or CNS Tumours Expressing EGFR |
https://ClinicalTrials.gov/show/NCT02687386 |
Recruiting |
Sydney Children’s Hospitals Network |
2021-02-28 |
| NCT02650401 |
Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options |
https://ClinicalTrials.gov/show/NCT02650401 |
Recruiting |
Hoffmann-La Roche |
2023-06-01 |
| NCT03213665 |
Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03213665 |
Recruiting |
National Cancer Institute (NCI) |
2024-09-30 |
| NCT02574728 |
Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors |
https://ClinicalTrials.gov/show/NCT02574728 |
Recruiting |
Emory University |
2022-01-31 |
| NCT03210714 |
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03210714 |
Recruiting |
National Cancer Institute (NCI) |
2024-12-31 |
| NCT03155620 |
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) |
https://ClinicalTrials.gov/show/NCT03155620 |
Recruiting |
National Cancer Institute (NCI) |
2027-09-30 |
| NCT03130959 |
An Investigational Immuno-therapy Study of Nivolumab Monotherapy and Nivolumab in Combination With Ipilimumab in Pediatric Patients With High Grade Primary CNS Malignancies |
https://ClinicalTrials.gov/show/NCT03130959 |
Active, not recruiting |
Bristol-Myers Squibb |
2021-06-14 |
| NCT00840047 |
Methionine PET/CT Studies In Patients With Cancer |
https://ClinicalTrials.gov/show/NCT00840047 |
Recruiting |
St. Jude Children’s Research Hospital |
2027-07-27 |
| NCT02496520 |
Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young Adults |
https://ClinicalTrials.gov/show/NCT02496520 |
Completed |
Clinica Universidad de Navarra, Universidad de Navarra |
2018-09-16 |
| NCT02462629 |
Study of BLZ-100 in Pediatric Subjects With CNS Tumors |
https://ClinicalTrials.gov/show/NCT02462629 |
Completed |
Blaze Bioscience Inc. |
2018-07-31 |
| NCT02451215 |
Laser Interstitial Thermal Therapy (LITT) for the Treatment of Pediatric Central Nervous System Tumors |
https://ClinicalTrials.gov/show/NCT02451215 |
Completed |
Children’s Hospitals and Clinics of Minnesota |
2020-01-31 |
| NCT02415153 |
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors |
https://ClinicalTrials.gov/show/NCT02415153 |
Active, not recruiting |
National Cancer Institute (NCI) |
2019-07-01 |
| NCT02343081 |
Bioequivalence Study of Temozolomide in Patients With Primary Tumors of the Central Nervous System |
https://ClinicalTrials.gov/show/NCT02343081 |
Completed |
Monte Verde SA |
2013-10-31 |
| NCT02323880 |
Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas |
https://ClinicalTrials.gov/show/NCT02323880 |
Recruiting |
Children’s Oncology Group |
2021-03-31 |
| NCT02164838 |
VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT02164838 |
Completed |
Children’s Oncology Group |
2017-10-19 |
| NCT02116777 |
Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies |
https://ClinicalTrials.gov/show/NCT02116777 |
Completed |
National Cancer Institute (NCI) |
2018-12-31 |
| NCT02100891 |
Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors |
https://ClinicalTrials.gov/show/NCT02100891 |
Recruiting |
Medical College of Wisconsin |
2020-12-31 |
| NCT02095132 |
Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT02095132 |
Active, not recruiting |
National Cancer Institute (NCI) |
2021-04-30 |
| NCT01273090 |
Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma |
https://ClinicalTrials.gov/show/NCT01273090 |
Completed |
Children’s Oncology Group |
2013-09-30 |
| NCT01941758 |
High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors |
https://ClinicalTrials.gov/show/NCT01941758 |
Completed |
Wake Forest University Health Sciences |
2014-11-30 |
| NCT01931098 |
Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab |
https://ClinicalTrials.gov/show/NCT01931098 |
Completed |
National Institutes of Health Clinical Center (CC) |
2019-09-12 |
| NCT01920191 |
Phase I/II Trial of IMA950 Multi-peptide Vaccine Plus Poly-ICLC in Glioblastoma |
https://ClinicalTrials.gov/show/NCT01920191 |
Completed |
University Hospital, Geneva |
2016-03-31 |
| NCT01709435 |
Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT01709435 |
Completed |
National Cancer Institute (NCI) |
2018-12-31 |
| NCT01538095 |
Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System Tumors |
https://ClinicalTrials.gov/show/NCT01538095 |
Completed |
National Cancer Institute (NCI) |
2016-04-30 |
| NCT01505569 |
Auto Transplant for High Risk or Relapsed Solid or CNS Tumors |
https://ClinicalTrials.gov/show/NCT01505569 |
Recruiting |
Masonic Cancer Center, University of Minnesota |
2021-03-31 |
| NCT01480050 |
Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma |
https://ClinicalTrials.gov/show/NCT01480050 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2015-08-31 |
| NCT01390571 |
Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma |
https://ClinicalTrials.gov/show/NCT01390571 |
Completed |
Cancer Research UK |
2017-06-20 |
| NCT01381718 |
Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor |
https://ClinicalTrials.gov/show/NCT01381718 |
Completed |
University of South Florida |
2016-08-31 |
| NCT01346267 |
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy |
https://ClinicalTrials.gov/show/NCT01346267 |
Completed |
University of South Florida |
2016-05-31 |
| NCT04217694 |
Memantine for the Reduction of Cognitive Impairment After Radiation Therapy in Pediatric Patients With Central Nervous System Tumors |
https://ClinicalTrials.gov/show/NCT04217694 |
Recruiting |
Mayo Clinic |
2022-12-30 |
| NCT04096716 |
Mapping Draining Lymph Nodes in CNS Malignancies |
https://ClinicalTrials.gov/show/NCT04096716 |
Recruiting |
Washington University School of Medicine |
2020-12-31 |
| NCT03990597 |
StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal Cord |
https://ClinicalTrials.gov/show/NCT03990597 |
Recruiting |
M.D. Anderson Cancer Center |
2020-05-31 |
| NCT03981016 |
Medical and Surgical Management of Patients With Brain Metastases |
https://ClinicalTrials.gov/show/NCT03981016 |
Active, not recruiting |
Institut du Cancer de Montpellier - Val d’Aurelle |
2018-01-19 |
| NCT03922555 |
ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas |
https://ClinicalTrials.gov/show/NCT03922555 |
Recruiting |
Massachusetts General Hospital |
2022-05-31 |
| NCT03899792 |
A Study of Oral LOXO-292 in Pediatric Patients With Advanced Solid or Primary Central Nervous System Tumors |
https://ClinicalTrials.gov/show/NCT03899792 |
Recruiting |
Loxo Oncology, Inc. |
2021-11-30 |
| NCT03838042 |
INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies |
https://ClinicalTrials.gov/show/NCT03838042 |
Recruiting |
University Hospital Heidelberg |
2022-09-30 |
| NCT03834961 |
Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia |
https://ClinicalTrials.gov/show/NCT03834961 |
Recruiting |
Children’s Oncology Group |
2022-05-11 |
| NCT03696355 |
Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline Gliomas |
https://ClinicalTrials.gov/show/NCT03696355 |
Active, not recruiting |
St. Jude Children’s Research Hospital |
2021-01-31 |
| NCT03690869 |
REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma |
https://ClinicalTrials.gov/show/NCT03690869 |
Recruiting |
Regeneron Pharmaceuticals |
2025-01-27 |
| NCT03638167 |
EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors |
https://ClinicalTrials.gov/show/NCT03638167 |
Recruiting |
Seattle Children’s Hospital |
2022-03-31 |
| NCT03598244 |
Volitinib in Treating Participants With Recurrent or Refractory Primary CNS Tumors |
https://ClinicalTrials.gov/show/NCT03598244 |
Recruiting |
National Cancer Institute (NCI) |
2020-12-31 |
| NCT03579602 |
Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing Surgery |
https://ClinicalTrials.gov/show/NCT03579602 |
Recruiting |
Blaze Bioscience Inc. |
2020-08-31 |
| NCT03500991 |
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors |
https://ClinicalTrials.gov/show/NCT03500991 |
Recruiting |
Seattle Children’s Hospital |
2021-07-26 |
| NCT03496402 |
Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO) |
https://ClinicalTrials.gov/show/NCT03496402 |
Recruiting |
Institut Curie |
2025-04-01 |
| NCT03434262 |
SJDAWN: St. Jude Children’s Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors |
https://ClinicalTrials.gov/show/NCT03434262 |
Recruiting |
St. Jude Children’s Research Hospital |
2025-02-28 |
| NCT01222221 |
Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT01222221 |
Completed |
Cancer Research UK |
2015-02-28 |
| NCT01164189 |
Bevacizumab in Recurrent Grade II and III Glioma |
https://ClinicalTrials.gov/show/NCT01164189 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2017-01-19 |
| NCT01158300 |
PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors |
https://ClinicalTrials.gov/show/NCT01158300 |
Completed |
Pediatric Brain Tumor Consortium |
2015-01-31 |
| NCT01135563 |
Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS Tumours |
https://ClinicalTrials.gov/show/NCT01135563 |
Completed |
The Hospital for Sick Children |
2012-04-30 |
| NCT01062399 |
Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT01062399 |
Active, not recruiting |
Radiation Therapy Oncology Group |
2016-06-30 |
| NCT01026493 |
Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma |
https://ClinicalTrials.gov/show/NCT01026493 |
Completed |
Radiation Therapy Oncology Group |
2014-05-31 |
| NCT01019434 |
Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma |
https://ClinicalTrials.gov/show/NCT01019434 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2013-12-31 |
| NCT00998010 |
Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma |
https://ClinicalTrials.gov/show/NCT00998010 |
Completed |
Jonsson Comprehensive Cancer Center |
2018-04-19 |
| NCT00990652 |
Presurgery Bortezomib for Recurrent Malignant Gliomas Followed by Postop Bortezomib & Temozolomide |
https://ClinicalTrials.gov/show/NCT00990652 |
Completed |
Northwestern University |
2011-04-30 |
| NCT00978458 |
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma |
https://ClinicalTrials.gov/show/NCT00978458 |
Active, not recruiting |
Eastern Cooperative Oncology Group |
2021-12-31 |
| NCT00974987 |
Boron Neutron Capture Therapy, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00974987 |
Completed |
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan |
2016-02-29 |
| NCT00945828 |
Assessing the Effectiveness of Individual Education Plans for Childhood Cancer Survivors |
https://ClinicalTrials.gov/show/NCT00945828 |
Completed |
University of Miami |
2010-10-31 |
| NCT00935545 |
Study of Peptide Vaccination With Tumor Associated Antigens Mixed With Montanide in Patients With CNS Tumors |
https://ClinicalTrials.gov/show/NCT00935545 |
Completed |
NYU Langone Health |
2014-01-31 |
| NCT00935090 |
3’-Deoxy-3’-[18F] Fluorothymidine PET Imaging in Patients With Cancer |
https://ClinicalTrials.gov/show/NCT00935090 |
Recruiting |
Barbara Ann Karmanos Cancer Institute |
2021-04-30 |
| NCT00905060 |
HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed GBM |
https://ClinicalTrials.gov/show/NCT00905060 |
Completed |
University of California, San Francisco |
2014-04-30 |
| NCT00895622 |
Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma |
https://ClinicalTrials.gov/show/NCT00895622 |
Active, not recruiting |
Radiation Therapy Oncology Group |
2016-09-30 |
| NCT00890032 |
Vaccine Therapy in Treating Patients Undergoing Surgery for Recurrent Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00890032 |
Completed |
Duke University |
2014-10-31 |
| NCT00887146 |
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma |
https://ClinicalTrials.gov/show/NCT00887146 |
Recruiting |
Alliance for Clinical Trials in Oncology |
2025-10-31 |
| NCT00876993 |
Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors |
https://ClinicalTrials.gov/show/NCT00876993 |
Completed |
Johns Hopkins All Children’s Hospital |
2015-09-30 |
| NCT00869401 |
Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00869401 |
Completed |
Alliance for Clinical Trials in Oncology |
2014-10-31 |
| NCT00867178 |
Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System |
https://ClinicalTrials.gov/show/NCT00867178 |
Active, not recruiting |
National Cancer Institute (NCI) |
2018-12-30 |
| NCT00832598 |
[18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors |
https://ClinicalTrials.gov/show/NCT00832598 |
Completed |
Memorial Sloan Kettering Cancer Center |
2017-03-21 |
| NCT00823524 |
Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer |
https://ClinicalTrials.gov/show/NCT00823524 |
Completed |
Asan Medical Center |
2013-02-28 |
| NCT04276194 |
Vertebral Body Sparing Craniospinal Irradiation for Pediatric Patients With Cancer of the Central Nervous System |
https://ClinicalTrials.gov/show/NCT04276194 |
Recruiting |
Emory University |
2021-12-31 |
| NCT04185038 |
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors |
https://ClinicalTrials.gov/show/NCT04185038 |
Recruiting |
Seattle Children’s Hospital |
2026-05-31 |
| NCT03911388 |
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors |
https://ClinicalTrials.gov/show/NCT03911388 |
Recruiting |
University of Alabama at Birmingham |
2023-09-01 |
| NCT02867592 |
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors |
https://ClinicalTrials.gov/show/NCT02867592 |
Recruiting |
National Cancer Institute (NCI) |
2020-09-30 |
| NCT03257631 |
A Study of Pomalidomide Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors |
https://ClinicalTrials.gov/show/NCT03257631 |
Active, not recruiting |
Celgene |
2018-11-23 |
| NCT03965494 |
AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing Surgery |
https://ClinicalTrials.gov/show/NCT03965494 |
Recruiting |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2022-12-01 |
| NCT00788125 |
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors |
https://ClinicalTrials.gov/show/NCT00788125 |
Active, not recruiting |
City of Hope Medical Center |
2023-09-30 |
| NCT00784914 |
A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors |
https://ClinicalTrials.gov/show/NCT00784914 |
Completed |
City of Hope Medical Center |
2010-11-30 |
| NCT00770471 |
ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00770471 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2012-03-01 |
| NCT00756340 |
A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid Tumors |
https://ClinicalTrials.gov/show/NCT00756340 |
Completed |
St. Jude Children’s Research Hospital |
2015-09-30 |
| NCT00752323 |
Imaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant Astrocytoma |
https://ClinicalTrials.gov/show/NCT00752323 |
Completed |
Case Comprehensive Cancer Center |
2018-09-15 |
| NCT00750009 |
Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial |
https://ClinicalTrials.gov/show/NCT00750009 |
Completed |
Case Comprehensive Cancer Center |
2012-12-31 |
| NCT00730613 |
Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00730613 |
Completed |
City of Hope Medical Center |
2011-08-31 |
| NCT00720564 |
Radiation Therapy, Arsenic Trioxide, and Temozolomide in Treating Patients With Newly Diagnosed High-Grade Glioma |
https://ClinicalTrials.gov/show/NCT00720564 |
Completed |
City of Hope Medical Center |
2009-02-28 |
| NCT00720356 |
Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma |
https://ClinicalTrials.gov/show/NCT00720356 |
Completed |
Northwestern University |
2014-06-24 |
| NCT00716976 |
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy |
https://ClinicalTrials.gov/show/NCT00716976 |
Completed |
Children’s Oncology Group |
2015-04-30 |
| NCT00666211 |
Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain |
https://ClinicalTrials.gov/show/NCT00666211 |
Completed |
Vanderbilt-Ingram Cancer Center |
2010-01-31 |
| NCT00820963 |
Standard Radiation Therapy, Higher-Dose Radiation Therapy, or Chemotherapy in Treating Older Patients With Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00820963 |
Completed |
National Cancer Institute (NCI) |
2011-05-31 |
| NCT00629889 |
Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors |
https://ClinicalTrials.gov/show/NCT00629889 |
Completed |
Centre Hospitalier Universitaire Vaudois |
2012-05-31 |
| NCT00626990 |
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH |
https://ClinicalTrials.gov/show/NCT00626990 |
Active, not recruiting |
European Organisation for Research and Treatment of Cancer - EORTC |
2022-01-31 |
| NCT00626730 |
Radiation Therapy in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Grade II or Grade III Meningioma |
https://ClinicalTrials.gov/show/NCT00626730 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2013-02-28 |
| NCT00621686 |
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00621686 |
Completed |
Alliance for Clinical Trials in Oncology |
2010-10-31 |
| NCT00619112 |
Temozolomide in Treating Patients With Recurrent High-Grade Glioma |
https://ClinicalTrials.gov/show/NCT00619112 |
Completed |
University of California, San Francisco |
2011-12-31 |
| NCT00612001 |
Vaccine Therapy in Treating Patients With Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00612001 |
Completed |
Jonsson Comprehensive Cancer Center |
2011-01-31 |
| NCT00602667 |
Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma |
https://ClinicalTrials.gov/show/NCT00602667 |
Active, not recruiting |
St. Jude Children’s Research Hospital |
2017-09-27 |
| NCT00589784 |
Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma |
https://ClinicalTrials.gov/show/NCT00589784 |
Completed |
Memorial Sloan Kettering Cancer Center |
2014-10-31 |
| NCT00553150 |
Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma |
https://ClinicalTrials.gov/show/NCT00553150 |
Completed |
Alliance for Clinical Trials in Oncology |
2012-01-31 |
| NCT00547131 |
Temozolomide in Treating Patients With Primary Brain Tumors or Metastatic Brain Tumors |
https://ClinicalTrials.gov/show/NCT00547131 |
Completed |
City of Hope Medical Center |
2008-05-31 |
| NCT00544284 |
Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment |
https://ClinicalTrials.gov/show/NCT00544284 |
Completed |
City of Hope Medical Center |
2012-01-31 |
| NCT00541138 |
Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors |
https://ClinicalTrials.gov/show/NCT00541138 |
Completed |
City of Hope Medical Center |
2007-10-31 |
| NCT00521183 |
Cytochlor, Tetrahydrouridine, and External-Beam Radiation Therapy in Treating Patients With Cancer That Has Spread to the Brain |
https://ClinicalTrials.gov/show/NCT00521183 |
Completed |
University of Miami |
2014-05-31 |
| NCT00513981 |
High-Dose Methotrexate in Treating Young Patients With Solid Tumors |
https://ClinicalTrials.gov/show/NCT00513981 |
Completed |
National Cancer Institute (NCI) |
2008-03-31 |
| NCT00509431 |
Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00509431 |
Completed |
Jonsson Comprehensive Cancer Center |
2011-12-31 |
| NCT00503724 |
Enzastaurin in Treating Young Patients With Refractory Primary CNS Tumors |
https://ClinicalTrials.gov/show/NCT00503724 |
Completed |
Pediatric Brain Tumor Consortium |
2010-05-31 |
| NCT00498927 |
Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00498927 |
Completed |
Memorial Sloan Kettering Cancer Center |
2013-12-31 |
| NCT00486603 |
Hydroxychloroquine, Radiation, and Temozolomide Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00486603 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2013-06-30 |
| NCT00482677 |
Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00482677 |
Completed |
Canadian Cancer Trials Group |
2016-03-01 |
| NCT00472017 |
Vandetanib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Diffuse Brainstem Glioma |
https://ClinicalTrials.gov/show/NCT00472017 |
Completed |
St. Jude Children’s Research Hospital |
2011-10-31 |
| NCT00470366 |
Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT00470366 |
Completed |
Memorial Sloan Kettering Cancer Center |
2016-06-30 |
| NCT00463008 |
Pharmacologic Study of Methotrexate in Patients Undergoing Stereotactic Biopsy for Recurrent High-Grade Glioma |
https://ClinicalTrials.gov/show/NCT00463008 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00452868 |
Donepezil in Treating Young Patients With Primary Brain Tumors Previously Treated With Radiation Therapy to the Brain |
https://ClinicalTrials.gov/show/NCT00452868 |
Completed |
Wake Forest University Health Sciences |
2010-02-28 |
| NCT00445965 |
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer |
https://ClinicalTrials.gov/show/NCT00445965 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-01-31 |
| NCT00424242 |
Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases |
https://ClinicalTrials.gov/show/NCT00424242 |
Active, not recruiting |
Northwestern University |
2020-03-31 |
| NCT00424060 |
Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma |
https://ClinicalTrials.gov/show/NCT00424060 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2007-08-31 |
| NCT00423852 |
Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin |
https://ClinicalTrials.gov/show/NCT00423852 |
Completed |
Memorial Sloan Kettering Cancer Center |
2013-02-28 |
| NCT00416923 |
Intrathecal Rituximab in Treating Patients With Recurrent CNS Lymphoma |
https://ClinicalTrials.gov/show/NCT00416923 |
Completed |
University of California, San Francisco |
2005-11-30 |
| NCT00416819 |
Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma |
https://ClinicalTrials.gov/show/NCT00416819 |
Completed |
University of California, San Francisco |
2005-12-31 |
| NCT00407433 |
Clinical Studies of Gemcitabine-Oxaliplatin |
https://ClinicalTrials.gov/show/NCT00407433 |
Completed |
Gustave Roussy, Cancer Campus, Grand Paris |
NA |
| NCT00404248 |
Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma |
https://ClinicalTrials.gov/show/NCT00404248 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2009-06-30 |
| NCT00401024 |
Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00401024 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2008-02-04 |
| NCT00400816 |
Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma |
https://ClinicalTrials.gov/show/NCT00400816 |
Completed |
The Cleveland Clinic |
2008-01-17 |
| NCT00390403 |
Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00390403 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2009-06-30 |
| NCT00389584 |
Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid Tumors |
https://ClinicalTrials.gov/show/NCT00389584 |
Completed |
University of California, Davis |
2006-11-30 |
| NCT00387933 |
Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00387933 |
Completed |
Duke University |
2009-01-31 |
| NCT00387400 |
Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00387400 |
Completed |
Canadian Cancer Trials Group |
2010-09-24 |
| NCT00376818 |
Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers |
https://ClinicalTrials.gov/show/NCT00376818 |
Completed |
Case Comprehensive Cancer Center |
2008-04-30 |
| NCT00357500 |
Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer |
https://ClinicalTrials.gov/show/NCT00357500 |
Completed |
Dana-Farber Cancer Institute |
2013-02-28 |
| NCT00357253 |
Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade Glioma |
https://ClinicalTrials.gov/show/NCT00357253 |
Completed |
Pediatric Brain Tumor Consortium |
2010-03-31 |
| NCT00354068 |
Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00354068 |
Completed |
Duke University |
2008-11-30 |
| NCT00352521 |
Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00352521 |
Completed |
Duke University |
2006-12-31 |
| NCT00352495 |
Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma |
https://ClinicalTrials.gov/show/NCT00352495 |
Completed |
Children’s Oncology Group |
2011-09-30 |
| NCT00352313 |
ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00352313 |
Completed |
National Institutes of Health Clinical Center (CC) |
2007-01-31 |
| NCT00348790 |
Vatalanib in Treating Patients With Recurrent or Progressive Meningioma |
https://ClinicalTrials.gov/show/NCT00348790 |
Completed |
Northwestern University |
2010-11-30 |
| NCT00337207 |
Bevacizumab in Treating Patients With Recurrent or Progressive Glioma |
https://ClinicalTrials.gov/show/NCT00337207 |
Completed |
Northwestern University |
2008-11-30 |
| NCT00331526 |
Cellular Adoptive Immunotherapy in Treating Patients With Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00331526 |
Completed |
Hoag Memorial Hospital Presbyterian |
2008-12-31 |
| NCT00329589 |
A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients |
https://ClinicalTrials.gov/show/NCT00329589 |
Completed |
Thomas Jefferson University |
2010-06-30 |
| NCT00328458 |
EPO906 Plus Radiation Therapy for the Treatment of Cancer Patients |
https://ClinicalTrials.gov/show/NCT00328458 |
Completed |
Thomas Jefferson University |
2008-05-31 |
| NCT00313729 |
Temozolomide in Treating Patients With Low-Grade Glioma |
https://ClinicalTrials.gov/show/NCT00313729 |
Completed |
University of California, San Francisco |
2014-09-25 |
| NCT00313599 |
Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT00313599 |
Completed |
University of California, San Francisco |
2013-12-31 |
| NCT00304031 |
Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma |
https://ClinicalTrials.gov/show/NCT00304031 |
Completed |
Radiation Therapy Oncology Group |
2011-02-28 |
| NCT00303940 |
Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors |
https://ClinicalTrials.gov/show/NCT00303940 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00303810 |
Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma |
https://ClinicalTrials.gov/show/NCT00303810 |
Completed |
Universitätsklinikum Hamburg-Eppendorf |
2013-12-31 |
| NCT00293423 |
GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma |
https://ClinicalTrials.gov/show/NCT00293423 |
Completed |
University of California, San Francisco |
2013-08-31 |
| NCT00293358 |
Combination Chemotherapy and Radiation Therapy in Treating Patients With Germ Cell Tumors in the Brain |
https://ClinicalTrials.gov/show/NCT00293358 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00276783 |
Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases |
https://ClinicalTrials.gov/show/NCT00276783 |
Active, not recruiting |
Northwestern University |
2022-12-31 |
| NCT00276770 |
Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas |
https://ClinicalTrials.gov/show/NCT00276770 |
Completed |
University of Washington |
2007-05-31 |
| NCT00276640 |
Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade Gliomas |
https://ClinicalTrials.gov/show/NCT00276640 |
Completed |
Societe Internationale d’Oncologie Pediatrique |
2015-12-31 |
| NCT00275067 |
Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery |
https://ClinicalTrials.gov/show/NCT00275067 |
Active, not recruiting |
Northwestern University |
2021-05-31 |
| NCT00275002 |
O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem Tumors |
https://ClinicalTrials.gov/show/NCT00275002 |
Completed |
National Cancer Institute (NCI) |
2010-07-31 |
| NCT00274833 |
Radiation Therapy, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00274833 |
Completed |
Case Comprehensive Cancer Center |
2007-10-31 |
| NCT00274755 |
Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas |
https://ClinicalTrials.gov/show/NCT00274755 |
Completed |
University of California, San Francisco |
2007-04-30 |
| NCT00268359 |
Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory Gliomas |
https://ClinicalTrials.gov/show/NCT00268359 |
Completed |
Duke University |
2006-08-31 |
| NCT00258453 |
Observation of Young Patients Who Are Undergoing Surgery for Craniopharyngioma |
https://ClinicalTrials.gov/show/NCT00258453 |
Completed |
National Cancer Institute (NCI) |
2007-09-30 |
| NCT00253487 |
Combination Chemotherapy and Radiation Therapy in Treating Younger Patients Who Are Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Gliomas |
https://ClinicalTrials.gov/show/NCT00253487 |
Completed |
National Cancer Institute (NCI) |
2012-08-31 |
| NCT00253448 |
Stereotactic Radiosurgery and Radiation Therapy in Treating Patients With Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00253448 |
Completed |
Case Comprehensive Cancer Center |
2009-12-31 |
| NCT00251797 |
A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors |
https://ClinicalTrials.gov/show/NCT00251797 |
Completed |
University of New Mexico |
2006-06-30 |
| NCT00238264 |
Radiation Therapy in Treating Young Patients With Gliomas |
https://ClinicalTrials.gov/show/NCT00238264 |
Completed |
Children’s Oncology Group |
2013-12-30 |
| NCT00187226 |
A Study for Image-Guided Radiation Therapy in Pediatric Brain Tumors and Side Effects |
https://ClinicalTrials.gov/show/NCT00187226 |
Active, not recruiting |
St. Jude Children’s Research Hospital |
2005-03-31 |
| NCT00185848 |
Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00185848 |
Completed |
Stanford University |
2013-06-30 |
| NCT00182819 |
Radiation Therapy or Temozolomide in Treating Patients With Gliomas |
https://ClinicalTrials.gov/show/NCT00182819 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2013-08-31 |
| NCT00152126 |
Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas |
https://ClinicalTrials.gov/show/NCT00152126 |
Completed |
St. Jude Children’s Research Hospital |
2005-08-31 |
| NCT00138216 |
Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT00138216 |
Completed |
Children’s Oncology Group |
2009-06-30 |
| NCT00128700 |
Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00128700 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2007-11-30 |
| NCT00128635 |
Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00128635 |
Completed |
Abramson Cancer Center of the University of Pennsylvania |
NA |
| NCT00124657 |
Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma |
https://ClinicalTrials.gov/show/NCT00124657 |
Completed |
St. Jude Children’s Research Hospital |
2012-07-31 |
| NCT00118222 |
High Light and Low Light Dose PDT in Glioma |
https://ClinicalTrials.gov/show/NCT00118222 |
Completed |
Case Comprehensive Cancer Center |
2006-03-31 |
| NCT00114140 |
Temozolomide and Radiation Therapy in Treating Patients With Gliomas |
https://ClinicalTrials.gov/show/NCT00114140 |
Active, not recruiting |
Radiation Therapy Oncology Group |
2013-02-28 |
| NCT00112502 |
Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00112502 |
Completed |
M.D. Anderson Cancer Center |
2014-09-30 |
| NCT00107458 |
Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors |
https://ClinicalTrials.gov/show/NCT00107458 |
Completed |
Children’s Oncology Group |
2007-10-31 |
| NCT00107237 |
AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00107237 |
Completed |
Novartis |
2006-06-30 |
| NCT00107185 |
Vaccine Therapy in Treating Young Patients Who Are Undergoing Surgery for Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00107185 |
Completed |
Jonsson Comprehensive Cancer Center |
2009-10-31 |
| NCT00105560 |
Proton Beam Radiation Therapy in Treating Young Patients Who Have Undergone Biopsy or Surgery for Medulloblastoma or Pineoblastoma |
https://ClinicalTrials.gov/show/NCT00105560 |
Active, not recruiting |
Massachusetts General Hospital |
2012-12-31 |
| NCT00100802 |
Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas |
https://ClinicalTrials.gov/show/NCT00100802 |
Completed |
Children’s Oncology Group |
2012-09-01 |
| NCT00099125 |
Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00099125 |
Completed |
Radiation Therapy Oncology Group |
2006-10-31 |
| NCT00099060 |
Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00099060 |
Completed |
National Cancer Institute (NCI) |
2007-11-30 |
| NCT00098865 |
Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or Neuroblastoma |
https://ClinicalTrials.gov/show/NCT00098865 |
Completed |
Dana-Farber Cancer Institute |
2010-06-30 |
| NCT00095771 |
Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas |
https://ClinicalTrials.gov/show/NCT00095771 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2011-01-31 |
| NCT00002543 |
Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin’s Lymphoma, or Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT00002543 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00003775 |
Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse |
https://ClinicalTrials.gov/show/NCT00003775 |
Completed |
Pfizer |
2006-05-31 |
| NCT00003625 |
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma |
https://ClinicalTrials.gov/show/NCT00003625 |
Completed |
Children’s Oncology Group |
2001-02-28 |
| NCT00003241 |
Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors |
https://ClinicalTrials.gov/show/NCT00003241 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00003134 |
Irinotecan in Treating Patients With Recurrent Glioma |
https://ClinicalTrials.gov/show/NCT00003134 |
Completed |
Alliance for Clinical Trials in Oncology |
2001-10-31 |
| NCT00003304 |
Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors |
https://ClinicalTrials.gov/show/NCT00003304 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2000-03-31 |
| NCT00003751 |
Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With Glioblastoma |
https://ClinicalTrials.gov/show/NCT00003751 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2004-06-30 |
| NCT00003348 |
Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain |
https://ClinicalTrials.gov/show/NCT00003348 |
Completed |
Duke University |
2000-08-31 |
| NCT00002749 |
Carboplatin in Patients With Progressive Gliomas |
https://ClinicalTrials.gov/show/NCT00002749 |
Completed |
Duke University |
NA |
| NCT00002619 |
Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Glioblastoma Multiforme or Brain Stem Tumors |
https://ClinicalTrials.gov/show/NCT00002619 |
Completed |
NYU Langone Health |
2000-04-30 |
| NCT00004937 |
Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00004937 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2000-05-31 |
| NCT00089245 |
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer |
https://ClinicalTrials.gov/show/NCT00089245 |
Active, not recruiting |
Y-mAbs Therapeutics |
2019-07-01 |
| NCT00004080 |
Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors |
https://ClinicalTrials.gov/show/NCT00004080 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00002824 |
Gene Therapy in Treating Patients With Primary Brain Tumors |
https://ClinicalTrials.gov/show/NCT00002824 |
Completed |
Abramson Cancer Center of the University of Pennsylvania |
NA |
| NCT00002754 |
Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors |
https://ClinicalTrials.gov/show/NCT00002754 |
Completed |
Duke University |
2001-04-30 |
| NCT00002753 |
Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas |
https://ClinicalTrials.gov/show/NCT00002753 |
Completed |
Duke University |
2001-04-30 |
| NCT00002572 |
Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors |
https://ClinicalTrials.gov/show/NCT00002572 |
Completed |
University of Colorado, Denver |
1999-12-31 |
| NCT00004041 |
Gene Therapy in Treating Patients With Recurrent Malignant Gliomas |
https://ClinicalTrials.gov/show/NCT00004041 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2002-07-22 |
| NCT00002620 |
Radiation Therapy in Treating Patients With Brain Cancer |
https://ClinicalTrials.gov/show/NCT00002620 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2000-06-30 |
| NCT00002545 |
Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00002545 |
Completed |
Radiation Therapy Oncology Group |
2004-12-31 |
| NCT00087061 |
Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00087061 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00086879 |
Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00086879 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2006-03-31 |
| NCT00005826 |
Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00005826 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2000-09-30 |
| NCT00003996 |
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00003996 |
Completed |
Alliance for Clinical Trials in Oncology |
2001-08-31 |
| NCT00003574 |
Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors |
https://ClinicalTrials.gov/show/NCT00003574 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00085566 |
Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00085566 |
Completed |
Memorial Sloan Kettering Cancer Center |
2008-02-29 |
| NCT00085202 |
Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor |
https://ClinicalTrials.gov/show/NCT00085202 |
Active, not recruiting |
St. Jude Children’s Research Hospital |
2016-12-31 |
| NCT00085098 |
Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell Tumor |
https://ClinicalTrials.gov/show/NCT00085098 |
Completed |
Children’s Oncology Group |
2009-05-31 |
| NCT00084838 |
Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT |
https://ClinicalTrials.gov/show/NCT00084838 |
Completed |
Dana-Farber Cancer Institute |
2008-02-29 |
| NCT00003859 |
Surgery Plus Radiation Therapy With or Without Chemotherapy in Treating Children With Primitive Neuroectodermal Tumors of the CNS |
https://ClinicalTrials.gov/show/NCT00003859 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00003410 |
Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas |
https://ClinicalTrials.gov/show/NCT00003410 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00003372 |
Topotecan in Treating Patients With Recurrent Brain Tumors |
https://ClinicalTrials.gov/show/NCT00003372 |
Completed |
Canadian Cancer Trials Group |
2000-10-05 |
| NCT00003939 |
Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma |
https://ClinicalTrials.gov/show/NCT00003939 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2000-11-30 |
| NCT00003293 |
SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00003293 |
Completed |
Pfizer |
2001-05-31 |
| NCT00006358 |
Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor |
https://ClinicalTrials.gov/show/NCT00006358 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2003-01-23 |
| NCT00002806 |
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma |
https://ClinicalTrials.gov/show/NCT00002806 |
Completed |
Alliance for Clinical Trials in Oncology |
2003-01-31 |
| NCT00002639 |
Suramin in Treating Patients With Recurrent Primary Brain Tumors |
https://ClinicalTrials.gov/show/NCT00002639 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00004200 |
Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00004200 |
Completed |
Pfizer |
2002-01-31 |
| NCT00003846 |
Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors |
https://ClinicalTrials.gov/show/NCT00003846 |
Completed |
Children’s Oncology Group |
2004-10-31 |
| NCT00002875 |
Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma |
https://ClinicalTrials.gov/show/NCT00002875 |
Completed |
Children’s Oncology Group |
2006-02-28 |
| NCT00002750 |
Melphalan in Patients With Neoplastic Meningitis |
https://ClinicalTrials.gov/show/NCT00002750 |
Completed |
Duke University |
2001-05-31 |
| NCT00004113 |
Temozolomide in Treating Patients With Recurrent Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00004113 |
Completed |
Memorial Sloan Kettering Cancer Center |
2001-10-31 |
| NCT00003101 |
Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma |
https://ClinicalTrials.gov/show/NCT00003101 |
Completed |
Memorial Sloan Kettering Cancer Center |
2002-01-31 |
| NCT00002876 |
Etoposide Plus Cisplatin in Treating Patients With Recurrent Ependymomas |
https://ClinicalTrials.gov/show/NCT00002876 |
Completed |
Mayo Clinic |
1998-04-30 |
| NCT00004073 |
Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00004073 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2003-05-31 |
| NCT00003876 |
Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00003876 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00003731 |
Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors |
https://ClinicalTrials.gov/show/NCT00003731 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2001-01-31 |
| NCT00082797 |
High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00082797 |
Completed |
Eastern Cooperative Oncology Group |
2007-05-31 |
| NCT00003020 |
LMB-7 Immunotoxin in Treating Patients With Leptomeningeal Metastases |
https://ClinicalTrials.gov/show/NCT00003020 |
Completed |
Duke University |
2000-09-30 |
| NCT00002988 |
Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00002988 |
Completed |
Duke University |
2000-11-30 |
| NCT00005081 |
Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma |
https://ClinicalTrials.gov/show/NCT00005081 |
Completed |
Duke University |
2001-04-30 |
| NCT00004892 |
O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00004892 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00005796 |
Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors |
https://ClinicalTrials.gov/show/NCT00005796 |
Completed |
Indiana University |
2003-06-30 |
| NCT00003765 |
O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors |
https://ClinicalTrials.gov/show/NCT00003765 |
Completed |
National Cancer Institute (NCI) |
2006-03-31 |
| NCT00005082 |
Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed Glioma |
https://ClinicalTrials.gov/show/NCT00005082 |
Completed |
Jonsson Comprehensive Cancer Center |
2000-11-30 |
| NCT00003621 |
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Anaplastic Astrocytoma |
https://ClinicalTrials.gov/show/NCT00003621 |
Completed |
Alliance for Clinical Trials in Oncology |
2005-02-28 |
| NCT00002463 |
Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors |
https://ClinicalTrials.gov/show/NCT00002463 |
Completed |
M.D. Anderson Cancer Center |
2007-01-31 |
| NCT00003301 |
Irinotecan in Treating Patients With Recurrent Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00003301 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00003176 |
Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma |
https://ClinicalTrials.gov/show/NCT00003176 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2001-12-03 |
| NCT00002814 |
Combination Chemotherapy for Patients With Brain Cancer |
https://ClinicalTrials.gov/show/NCT00002814 |
Completed |
Dartmouth-Hitchcock Medical Center |
2001-04-30 |
| NCT00022256 |
Motexafin Gadolinium Plus Radiation Therapy to the Brain in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00022256 |
Completed |
Memorial Sloan Kettering Cancer Center |
2003-04-30 |
| NCT00019071 |
Chemotherapy Followed by Radiation Therapy in Treating Patients With Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00019071 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00019058 |
Radiation Therapy in Treating Patients With Glioblastoma |
https://ClinicalTrials.gov/show/NCT00019058 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00014573 |
Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer |
https://ClinicalTrials.gov/show/NCT00014573 |
Completed |
Barbara Ann Karmanos Cancer Institute |
2004-10-31 |
| NCT00007813 |
Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors |
https://ClinicalTrials.gov/show/NCT00007813 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2005-02-01 |
| NCT00006368 |
Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer |
https://ClinicalTrials.gov/show/NCT00006368 |
Completed |
Novartis |
2003-11-30 |
| NCT00003657 |
High-dose ICE With Amifostine |
https://ClinicalTrials.gov/show/NCT00003657 |
Completed |
Dana-Farber Cancer Institute |
2000-11-30 |
| NCT00022360 |
Taurolidine in Treating Patients With Recurrent or Progressive Glioma |
https://ClinicalTrials.gov/show/NCT00022360 |
Completed |
Memorial Sloan Kettering Cancer Center |
2001-10-31 |
| NCT00014300 |
Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00014300 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2001-09-30 |
| NCT00003465 |
Temozolomide in Treating Patients With Anaplastic Oligodendroglioma |
https://ClinicalTrials.gov/show/NCT00003465 |
Completed |
Duke University |
NA |
| NCT00079092 |
Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00079092 |
Completed |
Wake Forest University Health Sciences |
2006-03-21 |
| NCT00078988 |
High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas |
https://ClinicalTrials.gov/show/NCT00078988 |
Completed |
Children’s Oncology Group |
2006-09-30 |
| NCT00006452 |
Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00006452 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2003-05-09 |
| NCT00002825 |
Docetaxel in Treating Children With Recurrent Solid Tumors |
https://ClinicalTrials.gov/show/NCT00002825 |
Completed |
National Cancer Institute (NCI) |
2004-12-31 |
| NCT00003935 |
Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma |
https://ClinicalTrials.gov/show/NCT00003935 |
Completed |
Children’s Oncology Group |
2003-10-31 |
| NCT00003573 |
Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma |
https://ClinicalTrials.gov/show/NCT00003573 |
Completed |
Children’s Oncology Group |
2007-10-31 |
| NCT00003916 |
Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating Patients With Glioma |
https://ClinicalTrials.gov/show/NCT00003916 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2001-12-31 |
| NCT00006388 |
Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00006388 |
Completed |
Radiation Therapy Oncology Group |
2003-10-31 |
| NCT00077207 |
Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma |
https://ClinicalTrials.gov/show/NCT00077207 |
Completed |
Children’s Oncology Group |
2010-03-31 |
| NCT00003616 |
Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00003616 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2002-05-17 |
| NCT00003185 |
Biological Therapy in Treating Patients With Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00003185 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00002840 |
Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma |
https://ClinicalTrials.gov/show/NCT00002840 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2002-03-31 |
| NCT00075894 |
Alanosine in Treating Patients With Progressive or Recurrent Malignant Gliomas |
https://ClinicalTrials.gov/show/NCT00075894 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00006353 |
Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00006353 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2002-03-31 |
| NCT00006080 |
Fenretinide in Treating Patients With Recurrent Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00006080 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2004-09-14 |
| NCT00074243 |
CC-8490 in Treating Patients With Recurrent or Refractory High-Grade Gliomas |
https://ClinicalTrials.gov/show/NCT00074243 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00003409 |
Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00003409 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00005813 |
Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00005813 |
Completed |
Dartmouth-Hitchcock Medical Center |
2003-01-31 |
| NCT00014677 |
NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00014677 |
Completed |
National Cancer Institute (NCI) |
2002-09-30 |
| NCT00003141 |
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors |
https://ClinicalTrials.gov/show/NCT00003141 |
Completed |
Children’s Oncology Group |
2007-12-31 |
| NCT00003234 |
Vinorelbine in Treating Children With Recurrent or Refractory Cancers |
https://ClinicalTrials.gov/show/NCT00003234 |
Completed |
Children’s Oncology Group |
2006-03-31 |
| NCT00070161 |
Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor |
https://ClinicalTrials.gov/show/NCT00070161 |
Completed |
Wake Forest University Health Sciences |
2005-05-31 |
| NCT00070096 |
Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT00070096 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00069940 |
Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor |
https://ClinicalTrials.gov/show/NCT00069940 |
Completed |
Dana-Farber Cancer Institute |
2006-08-31 |
| NCT00003463 |
Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas |
https://ClinicalTrials.gov/show/NCT00003463 |
Completed |
Duke University |
2002-07-31 |
| NCT00068510 |
Vaccine Therapy in Treating Patients With Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00068510 |
Completed |
Jonsson Comprehensive Cancer Center |
2012-09-30 |
| NCT00068250 |
Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma |
https://ClinicalTrials.gov/show/NCT00068250 |
Completed |
Radiation Therapy Oncology Group |
2016-12-31 |
| NCT00010036 |
Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00010036 |
Completed |
NYU Langone Health |
2001-10-31 |
| NCT00008086 |
Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT00008086 |
Completed |
University of Pittsburgh |
2004-09-30 |
| NCT00004004 |
Procarbazine in Treating Patients With Recurrent Brain Tumor |
https://ClinicalTrials.gov/show/NCT00004004 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00003464 |
Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00003464 |
Completed |
Duke University |
NA |
| NCT00066248 |
Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment |
https://ClinicalTrials.gov/show/NCT00066248 |
Completed |
University of South Florida |
2007-08-31 |
| NCT00003712 |
CCI-779 in Treating Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT00003712 |
Completed |
The University of Texas Health Science Center at San Antonio |
2002-06-30 |
| NCT00002965 |
Interferon Alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant Meningiomas |
https://ClinicalTrials.gov/show/NCT00002965 |
Completed |
M.D. Anderson Cancer Center |
2003-03-31 |
| NCT00064363 |
Talampanel in Treating Patients With Recurrent High-Grade Glioma |
https://ClinicalTrials.gov/show/NCT00064363 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00003211 |
Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
https://ClinicalTrials.gov/show/NCT00003211 |
Completed |
St. Jude Children’s Research Hospital |
2007-06-30 |
| NCT00036660 |
SarCNU in Treating Patients With Recurrent Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00036660 |
Completed |
Canadian Cancer Trials Group |
2003-04-15 |
| NCT00002752 |
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers |
https://ClinicalTrials.gov/show/NCT00002752 |
Completed |
Duke University |
2003-01-31 |
| NCT00027612 |
Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00027612 |
Completed |
Alliance for Clinical Trials in Oncology |
2006-10-31 |
| NCT00004868 |
SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy |
https://ClinicalTrials.gov/show/NCT00004868 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2004-09-15 |
| NCT00003203 |
Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors |
https://ClinicalTrials.gov/show/NCT00003203 |
Completed |
Children’s Oncology Group |
2007-10-31 |
| NCT00004068 |
Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor |
https://ClinicalTrials.gov/show/NCT00004068 |
Completed |
St. Jude Children’s Research Hospital |
2003-04-30 |
| NCT00002971 |
O(6)-Benzylguanine in Treating Patients With Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00002971 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2003-02-20 |
| NCT00003484 |
Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors |
https://ClinicalTrials.gov/show/NCT00003484 |
Completed |
Duke University |
2003-11-30 |
| NCT00003173 |
High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT00003173 |
Completed |
Memorial Sloan Kettering Cancer Center |
2003-05-31 |
| NCT00058370 |
Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma |
https://ClinicalTrials.gov/show/NCT00058370 |
Completed |
Memorial Sloan Kettering Cancer Center |
2019-06-30 |
| NCT00058123 |
Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma |
https://ClinicalTrials.gov/show/NCT00058123 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2007-10-06 |
| NCT00028678 |
Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00028678 |
Completed |
Eastern Cooperative Oncology Group |
2006-07-31 |
| NCT00053183 |
Surgery Followed by Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00053183 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00053118 |
Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer |
https://ClinicalTrials.gov/show/NCT00053118 |
Completed |
Roswell Park Cancer Institute |
2004-07-31 |
| NCT00052455 |
Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00052455 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00052286 |
Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer |
https://ClinicalTrials.gov/show/NCT00052286 |
Completed |
Jonsson Comprehensive Cancer Center |
2006-07-31 |
| NCT00049361 |
Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases |
https://ClinicalTrials.gov/show/NCT00049361 |
Completed |
Wake Forest University Health Sciences |
2004-12-07 |
| NCT00049023 |
Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT00049023 |
Completed |
University of Iowa |
2011-08-31 |
| NCT00047320 |
Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT00047320 |
Completed |
Children’s Oncology Group |
2009-02-28 |
| NCT00047294 |
Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00047294 |
Completed |
Dana-Farber Cancer Institute |
2005-03-31 |
| NCT00047281 |
Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00047281 |
Completed |
Dana-Farber Cancer Institute |
2005-08-31 |
| NCT00047177 |
Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor |
https://ClinicalTrials.gov/show/NCT00047177 |
Completed |
Pediatric Brain Tumor Consortium |
2004-08-31 |
| NCT00047073 |
Sirolimus in Treating Patients With Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00047073 |
Completed |
Jonsson Comprehensive Cancer Center |
2005-06-30 |
| NCT00045474 |
Brachytherapy in Treating Patients With Recurrent Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00045474 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00040911 |
Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma |
https://ClinicalTrials.gov/show/NCT00040911 |
Completed |
Children’s Oncology Group |
2009-10-31 |
| NCT00039572 |
Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain |
https://ClinicalTrials.gov/show/NCT00039572 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00039468 |
Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy |
https://ClinicalTrials.gov/show/NCT00039468 |
Completed |
Dartmouth-Hitchcock Medical Center |
2007-09-30 |
| NCT00039364 |
Imatinib Mesylate in Treating Patients With Gliomas |
https://ClinicalTrials.gov/show/NCT00039364 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2004-08-31 |
| NCT00036972 |
Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00036972 |
Completed |
National Cancer Institute (NCI) |
2005-01-31 |
| NCT00036959 |
ABT-751 in Treating Young Patients With Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT00036959 |
Completed |
National Institutes of Health Clinical Center (CC) |
2010-02-28 |
| NCT00036894 |
CC-5013 in Treating Patients With Recurrent Glioma |
https://ClinicalTrials.gov/show/NCT00036894 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00033280 |
Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas |
https://ClinicalTrials.gov/show/NCT00033280 |
Completed |
Radiation Therapy Oncology Group |
2005-04-30 |
| NCT00032097 |
Motexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the Brain |
https://ClinicalTrials.gov/show/NCT00032097 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00028795 |
Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma |
https://ClinicalTrials.gov/show/NCT00028795 |
Completed |
Children’s Oncology Group |
2007-09-30 |
| NCT00027846 |
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
https://ClinicalTrials.gov/show/NCT00027846 |
Completed |
Children’s Oncology Group |
2010-01-01 |
| NCT00027625 |
Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma |
https://ClinicalTrials.gov/show/NCT00027625 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2005-03-17 |
| NCT00025675 |
Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors |
https://ClinicalTrials.gov/show/NCT00025675 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2006-07-05 |
| NCT00025558 |
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer |
https://ClinicalTrials.gov/show/NCT00025558 |
Completed |
NYU Langone Health |
2007-05-31 |
| NCT00025311 |
Topotecan in Treating Patients With Recurrent, Progressive, or Refractory Cancer That is Metastatic to the Lining Around the Brain |
https://ClinicalTrials.gov/show/NCT00025311 |
Completed |
NYU Langone Health |
2003-10-31 |
| NCT00025077 |
Combination Chemotherapy, Surgery or Radiation Therapy, and Peripheral Stem Cell Transplant in Treating Patients With Recurrent Medulloblastoma or Primitive Neuroectodermal and Pineal Tumors |
https://ClinicalTrials.gov/show/NCT00025077 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00024258 |
Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors |
https://ClinicalTrials.gov/show/NCT00024258 |
Completed |
Memorial Sloan Kettering Cancer Center |
2009-05-31 |
| NCT00022724 |
CCI-779 in Treating Patients With Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00022724 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2006-05-04 |
| NCT00020150 |
Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors |
https://ClinicalTrials.gov/show/NCT00020150 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00019422 |
Lobradimil and Carboplatin in Treating Children With Brain Tumors |
https://ClinicalTrials.gov/show/NCT00019422 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00019019 |
Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas |
https://ClinicalTrials.gov/show/NCT00019019 |
Completed |
National Institutes of Health Clinical Center (CC) |
2006-07-31 |
| NCT00017264 |
Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00017264 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00016991 |
ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse |
https://ClinicalTrials.gov/show/NCT00016991 |
Completed |
Duke University |
NA |
| NCT00015899 |
SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors |
https://ClinicalTrials.gov/show/NCT00015899 |
Completed |
Pediatric Brain Tumor Consortium |
2005-09-30 |
| NCT00014521 |
Karenitecin in Treating Patients With Recurrent Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00014521 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00012038 |
Chemotherapy in Treating Patients With Progressive or Recurrent Brain Tumors |
https://ClinicalTrials.gov/show/NCT00012038 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00010049 |
Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma |
https://ClinicalTrials.gov/show/NCT00010049 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2005-03-17 |
| NCT00008008 |
Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00008008 |
Completed |
National Cancer Institute (NCI) |
2005-06-30 |
| NCT00007982 |
Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer |
https://ClinicalTrials.gov/show/NCT00007982 |
Completed |
National Cancer Institute (NCI) |
2005-02-28 |
| NCT00006474 |
Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma |
https://ClinicalTrials.gov/show/NCT00006474 |
Completed |
Duke University |
2004-08-31 |
| NCT00006386 |
Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00006386 |
Completed |
Radiation Therapy Oncology Group |
2004-11-30 |
| NCT00006355 |
Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00006355 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2004-10-31 |
| NCT00006268 |
Immunotoxin Therapy in Treating Patients With Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00006268 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00006258 |
Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma |
https://ClinicalTrials.gov/show/NCT00006258 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00006246 |
Busulfan in Treating Children and Adolescents With Refractory CNS Cancer |
https://ClinicalTrials.gov/show/NCT00006246 |
Completed |
Pediatric Brain Tumor Consortium |
2003-05-31 |
| NCT00006102 |
Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin’s Lymphoma |
https://ClinicalTrials.gov/show/NCT00006102 |
Completed |
National Cancer Institute (NCI) |
2006-06-30 |
| NCT00006093 |
EMD 121974 in Treating Patients With Progressive or Recurrent Glioma |
https://ClinicalTrials.gov/show/NCT00006093 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00006025 |
Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00006025 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2005-01-10 |
| NCT00006024 |
Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00006024 |
Completed |
Children’s Oncology Group |
2005-01-31 |
| NCT00005976 |
Pyrazoloacridine Plus Carboplatin in Treating Patients With Recurrent Glioma |
https://ClinicalTrials.gov/show/NCT00005976 |
Completed |
National Cancer Institute (NCI) |
2006-12-31 |
| NCT00005955 |
Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors |
https://ClinicalTrials.gov/show/NCT00005955 |
Completed |
Duke University |
NA |
| NCT00005954 |
Temozolomide in Treating Patients With Brain Metastases |
https://ClinicalTrials.gov/show/NCT00005954 |
Completed |
Duke University |
NA |
| NCT00005952 |
Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors |
https://ClinicalTrials.gov/show/NCT00005952 |
Completed |
Duke University |
2005-11-30 |
| NCT00005951 |
Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00005951 |
Completed |
Duke University |
2006-04-30 |
| NCT00005859 |
Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00005859 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2005-07-01 |
| NCT00005855 |
Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00005855 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00005637 |
Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00005637 |
Completed |
National Cancer Institute (NCI) |
2003-06-30 |
| NCT00005602 |
Radiation Therapy Plus Carboplatin and Lobradimil in Treating Children With Newly Diagnosed Brain Stem Gliomas |
https://ClinicalTrials.gov/show/NCT00005602 |
Completed |
Children’s Oncology Group |
2005-01-31 |
| NCT00005590 |
Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma |
https://ClinicalTrials.gov/show/NCT00005590 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00004259 |
Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas |
https://ClinicalTrials.gov/show/NCT00004259 |
Completed |
Radiation Therapy Oncology Group |
2015-02-01 |
| NCT00004224 |
Combination Chemotherapy Followed by Radiation Therapy in Treating Children With Localized Ependymoma |
https://ClinicalTrials.gov/show/NCT00004224 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00004212 |
DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas |
https://ClinicalTrials.gov/show/NCT00004212 |
Completed |
Daiichi Sankyo, Inc. |
2004-04-30 |
| NCT00004147 |
COL-3 in Treating Patients With Progressive or Recurrent Brain Tumors |
https://ClinicalTrials.gov/show/NCT00004147 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00004028 |
Carmustine in Treating Patients With Recurrent Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00004028 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00004024 |
Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma |
https://ClinicalTrials.gov/show/NCT00004024 |
Completed |
Barbara Ann Karmanos Cancer Institute |
2004-01-31 |
| NCT00004017 |
Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma |
https://ClinicalTrials.gov/show/NCT00004017 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00004015 |
Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery |
https://ClinicalTrials.gov/show/NCT00004015 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2003-07-31 |
| NCT00003478 |
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors |
https://ClinicalTrials.gov/show/NCT00003478 |
Completed |
Duke University |
2007-07-31 |
| NCT00003467 |
Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma |
https://ClinicalTrials.gov/show/NCT00003467 |
Completed |
Duke University |
NA |
| NCT00003466 |
Temozolomide in Treating Patients With Progressive Low-Grade Glioma |
https://ClinicalTrials.gov/show/NCT00003466 |
Completed |
Duke University |
2005-07-31 |
| NCT00003462 |
Intrathecal Busulfan in Treating Patients With Recurrent, Refractory, or Metastatic Leptomeningeal Tumors |
https://ClinicalTrials.gov/show/NCT00003462 |
Completed |
Duke University |
2001-02-28 |
| NCT00003461 |
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors |
https://ClinicalTrials.gov/show/NCT00003461 |
Completed |
Duke University |
2005-02-28 |
| NCT00003417 |
Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00003417 |
Completed |
Radiation Therapy Oncology Group |
2004-05-31 |
| NCT00003375 |
Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma |
https://ClinicalTrials.gov/show/NCT00003375 |
Completed |
Radiation Therapy Oncology Group |
2005-08-31 |
| NCT00003309 |
Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer |
https://ClinicalTrials.gov/show/NCT00003309 |
Completed |
Eastern Cooperative Oncology Group |
2004-03-31 |
| NCT00003022 |
Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer |
https://ClinicalTrials.gov/show/NCT00003022 |
Completed |
Memorial Sloan Kettering Cancer Center |
2005-01-31 |
| NCT00002986 |
Chemotherapy in Treating Patients With Recurrent Malignant Glioma |
https://ClinicalTrials.gov/show/NCT00002986 |
Completed |
Duke University |
2004-05-31 |
| NCT00002944 |
Combination Chemotherapy in Treating Children With Progressive Brain Tumors |
https://ClinicalTrials.gov/show/NCT00002944 |
Completed |
Children’s Oncology Group |
2006-02-28 |
| NCT00002931 |
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer |
https://ClinicalTrials.gov/show/NCT00002931 |
Completed |
City of Hope Medical Center |
2014-12-31 |
| NCT00002608 |
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors |
https://ClinicalTrials.gov/show/NCT00002608 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00002569 |
Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma |
https://ClinicalTrials.gov/show/NCT00002569 |
Completed |
Radiation Therapy Oncology Group |
2005-02-28 |
| NCT00002472 |
Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors |
https://ClinicalTrials.gov/show/NCT00002472 |
Completed |
Mayo Clinic |
2005-08-31 |
| NCT00098761 |
VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors |
https://ClinicalTrials.gov/show/NCT00098761 |
Completed |
Pediatric Brain Tumor Consortium |
2006-10-31 |
| NCT00031928 |
Mafosfamide in Treating Patients With Progressive or Refractory Meningeal Tumors |
https://ClinicalTrials.gov/show/NCT00031928 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00002594 |
Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT00002594 |
Completed |
Children’s Oncology Group |
2003-09-30 |
| NCT00030108 |
Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven’t Responded to Therapy |
https://ClinicalTrials.gov/show/NCT00030108 |
Completed |
National Institutes of Health Clinical Center (CC) |
2010-03-31 |